Myomectomy Market to Reach US$ 6.56 Billion by 2031 at 9.1% CAGR; North America Leads with 45% Share | Key Players Medtronic, Stryker, Intuitive Surgical

The Myomectomy Market reached US$ 2.84 billion in 2024 and is expected to reach US$ 6.56 billion by 2031, growing at a CAGR of 9.1% during the forecast period 2024-2031. Market growth is driven by the rising prevalence of uterine fibroids among women of reproductive age, increasing preference for uterus-preserving surgical procedures, and growing awareness of minimally invasive treatment options such as laparoscopic and robotic-assisted myomectomy.

Technological advancements in surgical instruments, improved imaging guidance, and shorter recovery times are further supporting market expansion. Hospitals remain the primary end users due to the availability of skilled gynecologic surgeons and advanced surgical infrastructure. North America dominates the market owing to higher diagnosis rates and adoption of advanced surgical techniques, while Asia-Pacific is expected to witness strong growth supported by expanding healthcare facilities, rising women's health awareness, and increasing healthcare expenditure.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/myomectomy-market?sai-v

The myomectomy market refers to the global industry focused on surgical procedures, devices, and techniques used to remove uterine fibroids while preserving the uterus.

Key Developments
✅ January 2026: In North America, adoption of robotic-assisted and minimally invasive myomectomy procedures grew as hospitals and specialty surgical centers expanded use of platforms from Intuitive Surgical (da Vinci System) and advanced laparoscopic tools from Medtronic to improve precision and reduce recovery times.

✅ January 2026: In Europe, clinical practice guidelines and surgical societies emphasized uterine-preserving myomectomy techniques (laparoscopic and hysteroscopic) to support fertility outcomes, with training programs backed by Olympus Corporation and Karl Storz.

✅ December 2025: In Asia-Pacific, rising prevalence of symptomatic uterine fibroids and increasing access to surgical care fueled growth in laparoscopic and hysteroscopic myomectomy services, supported by equipment from Stryker, Smith+Nephew, and B. Braun.

✅ December 2025: Globally, enhancements in intraoperative imaging and navigation systems improved fibroid localization and surgical planning, with contributions from GE Healthcare, Siemens Healthineers, and Medtronic.

✅ November 2025: In Latin America, expansion of ambulatory surgical centers offering myomectomy services improved access to care and reduced procedural costs, often leveraging technologies from Hologic and Stryker.

✅ October 2025: Worldwide, training initiatives by professional bodies and device manufacturers increased surgeon proficiency in fertility-preserving myomectomy techniques, with educational support from American Association of Gynecologic Laparoscopists (AAGL) and industry partners.

Mergers & Acquisitions
✅ January 2026: In the United States, Intuitive Surgical acquired a surgical imaging and guidance technology startup to enhance its robotic platforms for gynecologic procedures, including myomectomy.

✅ December 2025: In Europe, Medtronic completed the acquisition of a minimally invasive surgical instruments firm to broaden its portfolio of laparoscopic and hysteroscopic myomectomy tools.

✅ November 2025: In Asia-Pacific, Stryker acquired a regional surgical device company specializing in advanced laparoscopic instrumentation to strengthen its presence in women's health surgery.

Key Players
Medtronic PLC | Stryker Corporation | ConMed Corporation | INSIGHTEC Ltd | CooperSurgical Inc. | Hologic Inc. | Intuitive Surgical Inc. | KARL STORZ SE & Co. KG | B Braun | Richard Wolf Medical Instruments | Others

Key Highlights
Medtronic PLC holds 22% share, driven by its broad minimally invasive surgical portfolio, strong global footprint, and continuous innovation in surgical technologies.

Stryker Corporation holds 19% share, supported by advanced surgical instruments, robotics-assisted solutions, and strong adoption across hospitals and ambulatory centers.

Intuitive Surgical Inc. holds 16% share, leveraging leadership in robotic-assisted surgery, proprietary platforms, and high procedure volumes worldwide.

Hologic Inc. holds 12% share, driven by strength in women's health surgical solutions, imaging-guided procedures, and minimally invasive technologies.

KARL STORZ SE & Co. KG holds 9% share, supported by its leadership in endoscopy systems, precision optics, and strong clinician relationships.

B Braun holds 8% share, leveraging integrated surgical solutions, infection control expertise, and strong presence in hospital settings.

ConMed Corporation holds 6% share, driven by innovation in minimally invasive devices and orthopedic and general surgery instruments.

Richard Wolf Medical Instruments holds 4% share, focusing on endoscopic systems and specialized minimally invasive surgical solutions.

INSIGHTEC Ltd holds 3% share, supported by non-invasive focused ultrasound technology and growing adoption in neurosurgical applications.

CooperSurgical Inc. holds 1% share, specializing in reproductive health and minimally invasive surgical instruments.

Others collectively hold 0-5% share, comprising regional and niche medical device manufacturers offering specialized surgical technologies.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=myomectomy-market?sai-v

Market Drivers
- Increasing prevalence of uterine fibroids among women of reproductive age driving demand for myomectomy procedures.

- Growing focus on fertility-preserving surgical options as women seek treatments that maintain reproductive potential.

- Advancements in minimally invasive surgical techniques, including laparoscopic and robotic myomectomy, improving patient outcomes and recovery times.

- Rising awareness of treatment options and early diagnosis through improved gynecological screening and imaging.

- Increasing healthcare infrastructure development and access to specialty gynecologic care in emerging markets.

Industry Developments
- Expansion of robotic-assisted myomectomy procedures enhancing precision, reducing blood loss, and shortening hospital stays.

- Development of advanced imaging and surgical navigation systems to improve fibroid localization and procedural accuracy.

- Increasing availability of outpatient and same-day myomectomy services reducing treatment costs and improving patient convenience.

- Strategic partnerships between medical device manufacturers, healthcare providers, and training institutes to expand surgeon expertise and procedural adoption.

- Growing focus on enhanced recovery after surgery (ERAS) protocols and patient-centric perioperative care models.

Regional Insights
North America - 45% share: "Driven by high prevalence of uterine fibroids, advanced healthcare infrastructure, strong adoption of minimally invasive and robotic surgical techniques, and emphasis on fertility-preserving options."

Europe - 28% share: "Supported by well-established gynecological care networks, increasing use of laparoscopy and robotics, and growing patient awareness of minimally invasive treatments."

Asia Pacific - 20% share: "Fueled by rising fibroid incidence, expanding healthcare access, growing gynecologic surgical capabilities, and increasing adoption of advanced surgical technologies."

Latin America - 5% share: "Driven by improving gynecologic care infrastructure, rising awareness of fibroid treatment options, and increasing procedural adoption."

Middle East & Africa - 2% share: "Supported by emerging healthcare investments, expanding specialty care facilities, and growing focus on women's health."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/myomectomy-market?sai-v

Key Segments
By Type
Laparoscopic procedures account for a significant share due to their minimally invasive nature, reduced recovery time, and lower postoperative complications. Abdominal procedures continue to be widely used, particularly in complex cases requiring open surgical access. Hysteroscopic procedures are gaining adoption for intrauterine interventions owing to improved visualization and precision. Robotic-assisted procedures are witnessing strong growth, driven by enhanced surgical accuracy, ergonomics, and increasing investment in advanced surgical technologies.

By Product
Laparoscopic power morcellators hold a notable share, supported by their role in tissue extraction during minimally invasive gynecological surgeries. Laparoscopic sealers are increasingly adopted due to their ability to provide effective vessel sealing and reduced intraoperative blood loss. Harmonic scalpels are widely used for precise cutting and coagulation with minimal thermal damage. Other products include graspers, trocars, insufflators, and advanced energy devices that support efficient surgical outcomes.

By End-User
Hospitals and clinics dominate the market owing to high surgical volumes and access to advanced operating room infrastructure. Surgical centers account for a growing share, driven by the rising preference for outpatient and day-care procedures. Other end users include specialty gynecology centers and academic institutions involved in training and research.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.